8. Januar 2018, 18:00 bis 21:00 Uhr
KPMG LLP, 55 Second Street, San Francisco, CA 94105
sind leider nicht mehr möglich.
Die Anmeldefrist für die Veranstaltung ist leider abgelaufen.
Data-driven and patient-centered business models
How is big pharma reacting to the digital evolution? And what new business models will we see as machine and patient merge even more? Hear from industry heavyweight Novartis, from a Swiss femtech founder and Forbes "30 Under 30" 2018 winner, as well as from Roivant Sciences’ newest company – Datavant – how they transform life sciences through artificial intelligence, digital medicines and wearable technology.
This is a reception during #JPM18 you can't miss. Get first-hand industry insights and network with peers, potential clients and investors from Basel, Switzerland and beyond!
Please register via this link.